- Generic name
- Elagolix
- Strength
- 150 mg
- Dosage form
- Tablet
- Manufactured by
- The ACME Laboratories Ltd.
Egolix 150 Tablet
About Egolix 150 Tablet
Egolix 150 150 mg is a tablet product of The ACME Laboratories Ltd. that contains Elagolix. Endometriosis involves tissue similar to the uterine lining growing outside the uterus, which can lead to pain during periods, pelvic pain between periods and pain during sex.
There are 8 brands of Elagolix listed in Bangladesh. The lowest listed price is Elagox 150 mg Tablet at ৳ 170.00 per unit.
What is Egolix 150 Tablet?
Egolix 150 150 mg is a tablet product of The ACME Laboratories Ltd. that contains Elagolix. Egolix 150 150 mg tablet contains Elagolix, a gonadotropin-releasing hormone (GnRH) antagonist. It contains Elagolix 150 mg and belongs to a group of medicines called gonadotropin-releasing hormone antagonists. The dose and course are decided by your doctor, who will also check your suitability for this medicine.
Uses of Egolix 150
Endometriosis involves tissue similar to the uterine lining growing outside the uterus, which can lead to pain during periods, pelvic pain between periods and pain during sex. Elagolix works by blocking a hormone receptor that helps control estrogen, which in turn may reduce the growth and activity of endometrial-like tissue outside the uterus. Whether this medicine suits a particular person, and how long it should be taken, is decided by the doctor after assessing the symptoms and health history. Your doctor will decide whether this medicine is appropriate for your situation and how long it should be used.
How to use Egolix 150
Take Egolix 150 as your doctor directs. Egolix 150 is taken by mouth. Swallow the tablet with water. If you miss a dose or are unsure about anything, ask your doctor or pharmacist for guidance rather than adjusting the schedule on your own. Do not change the dose or stop early without asking your doctor.
Side effects of Egolix 150
Because mood changes can occur, tell your doctor if you feel low, anxious or notice any change in mood. Contact a doctor if side effects are bothersome or persistent, especially mood changes, depression, or thoughts of self-harm. Because the medicine can affect mood, patients should tell their doctor about any new or worsening depression, anxiety or thoughts of self-harm. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.
Safety and precautions
The medicine can reduce the ability to recognize pregnancy because it may alter menstrual bleeding, so testing is advised if pregnancy is suspected. Pregnancy should be excluded before starting, and the medicine should be stopped if pregnancy occurs. The doctor should assess individual risks before prescribing. Ask your doctor first if any of these apply to you.
Frequently asked questions
Why is Egolix 150 prescribed?
Endometriosis involves tissue similar to the uterine lining growing outside the uterus, which can lead to pain during periods, pelvic pain between periods and pain during sex. Elagolix works by blocking a hormone receptor that helps control estrogen, which in turn may reduce the growth and activity of endometrial-like tissue outside the uterus.
How do I use Egolix 150 correctly?
Take Egolix 150 as your doctor directs. Egolix 150 is taken by mouth.
Can Egolix 150 cause side effects?
Because mood changes can occur, tell your doctor if you feel low, anxious or notice any change in mood. Contact a doctor if side effects are bothersome or persistent, especially mood changes, depression, or thoughts of self-harm.
Can I use Egolix 150 in pregnancy or while breastfeeding?
The medicine can reduce the ability to recognize pregnancy because it may alter menstrual bleeding, so testing is advised if pregnancy is suspected. Pregnancy should be excluded before starting, and the medicine should be stopped if pregnancy occurs.
Indications
Pharmacology
Elagolix is an orally-administered, nonpeptide small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist that inhibits endogenous GnRH signaling by binding competitively to GnRH receptors in the pituitary gland Label. Administration of elagolix results in dose-dependent suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to decreased blood concentrations of the ovarian sex hormones, estradiol and progesterone.
Dosage & Administration
Initiate treatment with Elagolix 150 mg once daily-
- Maximum Treatment Duration: 24 months
- Coexisting Condition: None
- Maximum Treatment Duration: 6 months
- Coexisting Condition: Dyspareunia
- Maximum Treatment Duration: 6 months
- Coexisting Condition: Moderate hepatic impairment (Child-Pugh Class B)
Interaction
Contraindications
- Who are pregnant
- Exposure to ORILISSA early in pregnancy may increase the risk of early pregnancy loss.
- With known osteoporosis because of the risk of further bone loss
- With severe hepatic impairment because of the risk of bone loss
- With concomitant use of strong organic anion transporting polypeptide (OATP) 1B1 inhibitors (e.g., cyclosporine and gemfibrozil)
Side Effects
Pregnancy & Lactation
There are no adequate animal data on the excretion of Elagolix in milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Elagolix and any potential adverse effects on the breastfed child from Elagolix.
Precautions & Warnings
- Bone Loss: Dose- and duration-dependent decreases in bone mineral density (BMD) that may not be completely reversible. Assess BMD in women with additional risk factors for bone loss
- Reduced Ability to Recognize Pregnancy: Elagolix may alter menstrual bleeding, which may reduce the ability to recognize pregnancy. Perform testing if pregnancy is suspected. Discontinue if pregnancy is confirmed
- Suicidal Ideation and Mood Disorders: Advise patients to seek medical attention for suicidal ideation, suicidal behavior, new onset or worsening depression, anxiety, or other mood changes
- Hepatic Transaminase Elevations: Dose-dependent elevations in serum alanine aminotransferase (ALT). Counsel patients on signs and symptoms of liver injury
- Potential for Reduced Efficacy with Estrogen-Containing Contraceptives: Use non-hormonal contraception during treatment and for one week after discontinuing Elagolix.
Overdose Effects
Storage Conditions
Alternative brands of Elagolix
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.